Market Place
Sourcing Support
Investor pleads guilty to insider trading in Alzheimer`s biotech
28 Jul 2022 //
FIERCEBIOTECH
Neurotrope, Inc. Completes Independent Spin-off of Neurotrope Bioscience
08 Dec 2020 //
PRNEWSWIRE
Neurotrope and Metuchen Pharmaceuticals Announce Completion
02 Dec 2020 //
PRNEWSWIRE
Neurotrope Announces Investor Update Conference Call
02 Dec 2020 //
COM
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger
02 Dec 2020 //
PRNEWSWIRE
Neurotrope approves spin-off of Neurotrope Bioscience
20 Nov 2020 //
SEEKING ALPHA
Neurotrope Announces 1st Patient Dosed in Long-Term Clinical Trial of Bryostatin
06 Oct 2020 //
PRNEWSWIRE
Neurotrope Announces Investor Update Conference Call
26 May 2020 //
PR NEWSWIRE
Neurotrope Announces Investor Update Conference Call
26 May 2020 //
PR NEWSWIRE
Neurotrope & Metuchen Pharmac Announce Merger Agreement to Form Petros
18 May 2020 //
PRNEWSWIRE
Obliterated by Alzheimer`s failure, Neurotrope relinquishes reverse merger
18 May 2020 //
ENDPTS
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis
22 Jan 2020 //
PR NEWSWIRE
Investors lost big as Alzheimer’s R&D went over the cliff in 2019
11 Sep 2019 //
ENDPOINTS NEWS
Neurotrope shares crash after Alzheimer`s drug fails in trial
10 Sep 2019 //
REUTERS
Neurotrope Completes Enrollment Of Confirmatory Phase 2 Study of Bryostatin-1
13 Mar 2019 //
PR NEWSWRE
Neurotrope Announces Cooperative Research and Development Agreement for Bryostatin-1 with NCI
04 Feb 2019 //
PR NEWSWIRE
Neurotrope & NCI Enter Development Agreement
04 Jan 2019 //
CONTRACT PHARMA
Neurotrope Enters Collaboration with Nemours forFragile X Syndrome
06 Sep 2018 //
PR NEWSWIRE
Neurotrope announces +ve top-line results from phase 2 study of Bryostatin-1
02 May 2017 //
PHARMABIZ
Neurotrope completes patient dosing in phase 2 study of bryostatin
24 Nov 2016 //
PHARMABIZ
Neurotrope raises $20M, set to finish PhII Alzheimer’s test
18 Nov 2016 //
FIERCE BIOTECH
Neurotrope collaborates with research institutions to examine effect of bryostatin in NPC mice
26 Jun 2015 //
PHARMABIZ
Neurotrope Receives FDA Orphan Drug Designation for Bryostatin in the Treatment of Fragile X Syndrome
09 Apr 2015 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.